Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Find a clinical trial that's recruiting now
Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.
- 24,857
- trials recruiting now
- 14%
- of all US trials open to enrollment
- 52
- states with recruiting sites
A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.
Popular conditions
100 trials found
Molecular Genetics Studies of Cancer Patients and Their Relatives
City of Hope Medical Center
NCT04185935
Generic Database of Very Low Birth Weight Infants
NICHD Neonatal Research Network
NCT00063063
Follow-up Visit of High Risk Infants
NICHD Neonatal Research Network
NCT00009633
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
New Mexico Cancer Research Alliance
NCT03977402
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
N-Power Medicine
NCT06877884
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
University of New Mexi
NCT05140265
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Ohio State University
NCT06468202
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Yale University
NCT06030063
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
Vaxcyte
NCT07284654
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
George Washington University
NCT06525259
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
VA Office of Research and Development
NCT05931276
Neonatal Platelet Transfusion Threshold Trial
NICHD Neonatal Research Network
NCT06676904
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Duke University
NCT03511118
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Ohio State University
NCT06445946
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
Stalicla
NCT05590715
End-Tidal Oxygen for Intubation in the Emergency Department
Sydney Local Health District
NCT06578468
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Kura Oncology
NCT07007312
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
NYU Langone Health
NCT04474223
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Jason Sperry
NCT05958342
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
New Mexico Cancer Research Alliance
NCT06207864
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Merck Sharp & Dohme
NCT07060807
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Bristol-Myers Squibb
NCT06561386
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Olema Pharmaceuticals
NCT07085767
Treatment of Brain AVMs (TOBAS) Study
Centre hospitalier de l'Université de Montréal (CHUM)
NCT02098252
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Philip Spinella
NCT06070350
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Merck Sharp & Dohme
NCT06422143
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Gilead Sciences
NCT03547973
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
NCT07369011
Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
HELP for NOWS Consortium
NCT07278375
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
SWOG Cancer Research Network
NCT05642611
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Merck Sharp & Dohme
NCT06824467
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Zimmer Biomet
NCT05787821
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis
Janssen Research & Development
NCT06807424
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Amgen
NCT05920356
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
National Cancer Institute (NCI)
NCT06498661
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
Vaxcyte
NCT07425392
Suicide in Urban Natives: Detection and Networks to Combat Events
University of Colorado, Denver
NCT03136094
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Gilead Sciences
NCT06801834
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Merck Sharp & Dohme
NCT06459180
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche
NCT06793215
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
NRG Oncology
NCT06279013
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
NCT07196501
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Bristol-Myers Squibb
NCT06646276
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Karyopharm Therapeutics
NCT04442022
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
University of New Mexi
NCT04185844
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
National Cancer Institute (NCI)
NCT07281430
Collection of Sputum and Labeling for Lung Cancer
bioAffinity Technologies
NCT03457415
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Johnson & Johnson Enterprise Innovation
NCT04892173
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Merus B.V.
NCT06525220
Psilocybin for Opioid Use Disorder (OUD)
NYU Langone Health
NCT06796062
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Novartis Pharmaceuticals
NCT05126277
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
AstraZeneca
NCT05123482
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
AstraZeneca
NCT05489211
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Amgen
NCT06700343
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Exelixis
NCT06943755
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Women and Infants Hospital of Rhode Island
NCT05806164
Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Specimens
Abbott Point of Care
NCT07287618
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
Abbott Point of Care
NCT07287631
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
University of Pittsburgh
NCT06978127
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
Inhibrx Biosciences
NCT06295731
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Boston Scientific Corporation
NCT06735534
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Beth Israel Deaconess Medical Center
NCT06896474
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Pfizer
NCT06163326
Transformative Research in Diabetic Nephropathy
University of Pennsylvania
NCT02986984
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Janssen Research & Development
NCT04811560
Wearable Spine Health System for Military Readiness
Ohio State University
NCT05944354
BostonGene and Exigent Genomic INsight Study
BostonGene
NCT06272864
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
UCB Biopharma SRL
NCT07290036
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Atom Therapeutics Co.
NCT07145229
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Vicore Pharma AB
NCT06588686
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
NCT06846281
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
VA Office of Research and Development
NCT04373317
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
BioNTech SE
NCT04534205
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Abiomed
NCT06964685
Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women
The Mind Research Network
NCT05845333
Distal Radius Interventions for Fracture Treatment
Ann & Robert H Lurie Children's Hospital of Chicago
NCT05131685
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
NICHD Neonatal Research Network
NCT06679855
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme
NCT07133633
A Study of YL201 in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co.
NCT05434234
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Eli Lilly and Company
NCT06817356
Desara ® One Single Incision Sling 522 Study
Caldera Medical
NCT04772131
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Merck Sharp & Dohme
NCT05139017
Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders
The Mind Research Network
NCT06981351
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Ipsen
NCT06016842
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Corcept Therapeutics
NCT06906341
Study of LYL314 in Aggressive Large B-Cell Lymphoma
Lyell Immunopharma
NCT05826535
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Alebund Pharmaceuticals
NCT06933472
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
VA Office of Research and Development
NCT05465044
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co.
NCT06459973
Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
University of Illinois at Chicago
NCT04717427
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
Wake Forest University Health Sciences
NCT05703269
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology
NCT03556228
WEAVE NM: Heart Health and Nutrition for Life
University of New Mexi
NCT07074145
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
VistaGen Therapeutics
NCT06615557
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
DT MedTech
NCT04770870
Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection
University of New Mexi
NCT06268704
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
Clarity Pharmaceuticals
NCT06970847
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Astellas Pharma Global Development
NCT07005154
Carbon Dioxide Administration and Brain Waste Clearance
Andrew Mayer
NCT07357090
An Observational Study of Individuals With Isolated Dystonia
Vima Therapeutics
NCT07111663
Read our methodology - how recruiting status is sourced and refreshed from the public registry.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.